Mr. ZHOU Qiyuan (周启元)

?
Filters
Filters

Reset

to
1 - 3 out of 3Page size: 20

Research Output

  1. 2020
  2. Published

    Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues

    Chen, S., Yao, H., Zhou, Q., Tse, M., Gunawan, Y. F. & Zhu, G., 17 Aug 2020, In : Inorganic Chemistry. 59, 16, p. 11676–11687

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal

    Check@CityULib
  3. Accepted/In press/Filed

    Platinum Complex, Its Preparation and Therapeutic Use

    ZHU, G., XU, Z. & ZHOU, Q., 22 May 2020, (Accepted/In press/Filed) Priority No. 63/028,646

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53) › 51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  4. 2019
  5. Published

    Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors

    Xu, Z., Li, C., Zhou, Q., Deng, Z., Tong, Z., Tse, M. & Zhu, G., 2 Dec 2019, In : Inorganic Chemistry. 58, 23, p. 16279-16291

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal

    Scopus citations: 2
    Check@CityULib